These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 5551655)

  • 1. Presence of alpha-anomeric glycosidic configuration in the glycolipids accumulated in kidney with Fabry's disease.
    Handa S; Ariga T; Miyatake T; Yamakawa T
    J Biochem; 1971 Mar; 69(3):625-7. PubMed ID: 5551655
    [No Abstract]   [Full Text] [Related]  

  • 2. Enzyme transplantation in Fabry's disease.
    Krivit W; Desnick RJ; Bernlohr RW; Wold F; Najarian JS; Simmons RL
    N Engl J Med; 1972 Dec; 287(24):1248-9. PubMed ID: 4563680
    [No Abstract]   [Full Text] [Related]  

  • 3. Enzyme replacement therapy by renal allotransplantation in Fabry's disease.
    Clarke JT; Guttmann RD; Wolfe LS; Beaudoin JG; Morehouse DD
    N Engl J Med; 1972 Dec; 287(24):1215-8. PubMed ID: 4563677
    [No Abstract]   [Full Text] [Related]  

  • 4. Anomeric structure of ceramide digalactoside isolated from the kidney of a patient with Fabry's disease.
    Li YT; Li SC; Dawson G
    Biochim Biophys Acta; 1972 Jan; 260(1):88-92. PubMed ID: 5012456
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biochemistry of Fabry's disease].
    Kint JA; Dacremont G
    Arch Belg Dermatol Syphiligr; 1972; 28(3):245-50. PubMed ID: 4664703
    [No Abstract]   [Full Text] [Related]  

  • 6. Fabry's disease: structural or regulatory mutation?
    Beutler E; Kuhl W
    J Lab Clin Med; 1971 Dec; 78(6):987. PubMed ID: 5131867
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fabry-Anderson's disease].
    Andratschke C
    Fortschr Med; 1975 Dec; 93(34):1697-702. PubMed ID: 811519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of cross-reactive antigen in Fabry's disease.
    Beutler E; Kuhl W
    N Engl J Med; 1973 Sep; 289(13):694-5. PubMed ID: 4199465
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal transplantation in Fabry's disease.
    Peters PC; Leeber D; Hull AR; Philippart M
    Trans Am Assoc Genitourin Surg; 1972; 64():36-8. PubMed ID: 4569857
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence for a terminal -D-galactopyranosyl residue in galactosylgalactosylglucosylceramide from human kidney.
    Clarke JT; Wolfe LS; Perlin AS
    J Biol Chem; 1971 Sep; 246(18):5563-9. PubMed ID: 5096082
    [No Abstract]   [Full Text] [Related]  

  • 11. Correction of the enzymic defect in cultured fibroblasts from patients with Fabry's disease: treatment with purified alpha-galactosidase from ficin.
    Dawson G; Matalon R; Li YT
    Pediatr Res; 1973 Aug; 7(8):684-90. PubMed ID: 4732107
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversal of an inborn sphingolipidosis (Fabry's disease) by kidney transplantation.
    Philippart M; Franklin SS; Gordon A
    Ann Intern Med; 1972 Aug; 77(2):195-200. PubMed ID: 4565790
    [No Abstract]   [Full Text] [Related]  

  • 13. Fabry's disease: differentiation between two forms of -galactosidase by myoinositol.
    Crawhall JC; Banfalvi M
    Science; 1972 Aug; 177(4048):527-8. PubMed ID: 5050485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biochemical abnormalities in Fabry's disease.
    Kint JA; Dacremont G
    Arch Int Physiol Biochim; 1970 Feb; 78(1):169-71. PubMed ID: 4100872
    [No Abstract]   [Full Text] [Related]  

  • 15. Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes.
    Desnick RJ; Allen KY; Desnick SJ; Raman MK; Bernlohr RW; Krivit W
    J Lab Clin Med; 1973 Feb; 81(2):157-71. PubMed ID: 4683418
    [No Abstract]   [Full Text] [Related]  

  • 16. Kidney transplantation in Fabry's disease.
    Philippart M; Franklin SS; Leeber DA; Hull AR; Peters PC
    N Engl J Med; 1973 Aug; 289(5):270-1. PubMed ID: 4197403
    [No Abstract]   [Full Text] [Related]  

  • 17. [Autopsy case of Fabry's disease].
    Yoshitoshi Y; Nagata N; Nakamura K; Nishio I
    Naika; 1971 May; 27(5):983-7. PubMed ID: 5572502
    [No Abstract]   [Full Text] [Related]  

  • 18. Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry's disease.
    Brady RO; Tallman JF; Johnson WG; Gal AE; Leahy WR; Quirk JM; Dekaban AS
    N Engl J Med; 1973 Jul; 289(1):9-14. PubMed ID: 4196713
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fabry's disease].
    Miyashita T
    Naika; 1971; 28(3):470-1. PubMed ID: 5097710
    [No Abstract]   [Full Text] [Related]  

  • 20. Fabry's disease as an -galactosidosis: evidence for an -configuration in trihexosyl ceramide.
    Bensaude I; Callahan J; Philippart M
    Biochem Biophys Res Commun; 1971 May; 43(4):913-8. PubMed ID: 5563756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.